Little Green Pharma Stands Out Amid The Crowded Cannabis Canopy


15 May 2020

Researcher viewing cannabis
Little Green Pharma Stands Out Amid The Crowded Cannabis Canopy

With dozens of medicinal cannabis plays now listed on the ASX and with many pretenders along for the ride, the serious exponents need to offer investors more than opaque promises about exploiting the healing herb.

This is ever more the case given the so-called ‘green gold’ is at risk of becoming a commoditised market – especially in jurisdictions such as the US where recreational pot is widely legalised.

So how do the genuine players stand out above the canopy of chancers?

Little Green Pharma (ASX:LGP) has some genuine pioneering notches on its belt.

The Perth-based outfit was the first to produce a home-grown medicinal cannabis product for patient use (in August 2018) and it was also the first to export when it became legal to do so.

“Even today we are the only local producer among the 130 products available,” says LGP founder and CEO Fleta Solomon.

“There are lots of licences issued and a lot of people growing, but no-one has actually produced the finished medicines.”

LGP is also generating meaningful revenue: a unicorn-type rarity in the sector.

Read the full article here:

You might also be interested in

STATS 150321 News 1400x1400

Regulatory News

Industry Update: February 2021
The Therapeutic Goods Administration (TGA), has set its largest month on record for Medicinal cannabis approvals.

Mar 2021

LGP Manufacturing 1200x1200

Company news

Good Manufacturing Practices licence granted
Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia.

Oct 2020


Company news

GreenChoices launches

Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.

Aug 2018

View all articles